Carna Biosciences (TSE:4572) Ending Cash Position : 円0 Mil (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Ending Cash Position?

Carna Biosciences's Ending Cash Position for the quarter that ended in Dec. 2024 was 円0 Mil.

Carna Biosciences's annual Ending Cash Position declined from Dec. 2022 (円3,379 Mil) to Dec. 2023 (円2,889 Mil) and declined from Dec. 2023 (円2,889 Mil) to Dec. 2024 (円2,108 Mil).

Carna Biosciences Ending Cash Position Historical Data

The historical data trend for Carna Biosciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Ending Cash Position Chart

Carna Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

4,299.14

3,817.83

3,379.05

2,889.10

2,108.48

Carna Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Carna Biosciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Carna Biosciences's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2889.1	+	-780.616
	=	2,108

Carna Biosciences's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Carna Biosciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.

Carna Biosciences Headlines

No Headlines